ICLR Icon Plc
422
$315.70
$0.56
(0.18%)
| Watchers | 422 |
| 52-Wk Low | $185.27 |
| 52-Wk High | $344.77 |
| Market Cap | $26.06B |
| Volume | 149,879.00 |
| 52-Wk High | $344.77 |
| 52-Wk Low | $185.27 |
ICON Announces Pricing of USD 2 Billion NotesBusiness Wire • 7 days ago
ICON plc (NASDAQ: ICLR) (ICON), a world-leading healthcare intelligence and clinical research organization, today announced the pricing of a USD 2 billion SEC-registered bond offering, consisting of...
Share to Feed
ICON Public (NASDAQ:ICLR - Free Report) had its target price raised by Robert W. Baird from $345.00 to $362.00 in a research report sent to investors on Thursday, Benzinga reports. Robert W. Baird...
ICON Public (NASDAQ:ICLR - Get Free Report)s stock had its "buy" rating restated by equities research analysts at Mizuho in a report issued on Thursday, Benzinga reports. They presently have a...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Chief Financial Officer, Brendan Brennan, will leave his role at ICON in...
TimesSquare Capital Management, an equity investment management company, released its U.S. Mid Cap Growth Strategy fourth-quarter investor letter. A copy of the same can be downloaded here. In the...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the first quarter 2024 after the...
Shares of ICON Public Limited (NASDAQ:ICLR Get Free Report) have been assigned a consensus rating of Buy from the eight brokerages that are currently covering the stock...
TimesSquare Capital Management LLC cut its holdings in shares of ICON Public Limited (NASDAQ:ICLR Free Report) by 4.9% in the third quarter, according to its most recent filing with the...
ICON Public (NASDAQ:ICLR Free Report) had its price target lifted by Mizuho from $315.00 to $346.00 in a research report report published on Friday morning, Benzinga reports. The brokerage...
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organization powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the TD Cowen...